DAESHIN MC Targets Singapore Market with Smart Cleaning Solutions at 'BEX ASIA 2025'
At this exhibition, DAESHIN MC will showcase two cutting-edge cleaning solutions designed to enhance hygiene infrastructure in multi-use facilities: 'SoleCheck' and 'Caster Cleaner'. These products are intended for a wide range of applications, including hospitals, airports, schools, government facilities, and smart buildings. They are recognized as solutions aligned with Singapore's urban development and smart city construction strategies.The flagship product 'SoleCheck' is a contactless smart cleaning mat that automatically suctions dust and contaminants from shoe soles simply by walking across the mat, effectively preventing the spread of airborne particles. Its modular design enables convenient partial replacement and maintenance, offering long-term cost savings. The product is currently being actively used in domestic public institutions, research facilities, and airports.The accompanying 'Caster Cleaner' is a technology that automatically cleans the wheels of transport carts used in industrial sites, hospitals, food processing plants, and logistics centers, fundamentally blocking contaminants from entering indoor spaces. It is recognized as the world's first automatic wheel cleaning system. High demand is particularly anticipated in Singapore's medical and logistics sectors, where stringent hygiene standards are in place.
A DAESHIN MC representative stated, "Under the philosophy that floor cleanliness is the foundation of overall spatial hygiene, we aim to present effective cleaning solutions even in ultra-high-density urban environments like Singapore. Through our participation in BEX ASIA 2025, we plan to actively promote the excellence of 'Korean-style smart hygiene technology' in the Southeast Asian market."
Social Links
YouTube: https://www.youtube.com/@corp.daeshinmc7691
LinkedIn: https://www.linkedin.com/in/yoona-choi-0156/
Media Contact
Brand: DAESHIN MC CO.,LTD
Contact: Media Team
Tel : +82-10-6707-0156
Email: dsclean@dsclean.co.kr
Website: http://www.daeshinmc.co.kr/en/Sign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Aethlon Medical Inc (AEMD) Q1 2026 Earnings Call Highlights: Strategic Focus on Australian ...
Release Date: August 13, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Aethlon Medical Inc (NASDAQ:AEMD) has made significant progress in its Australian oncology trial, with the first cohort of patients completing treatment without any device deficiencies or serious adverse events. The company has received formal approval from India's CDSCO to initiate an oncology trial, although they have decided to focus resources on the Australian trial for strategic reasons. Aethlon Medical Inc (NASDAQ:AEMD) has significantly reduced operating expenses by approximately 32%, primarily through payroll savings and reduced legal and consulting fees. The company is actively exploring the use of its hemo purifier for broader applications, including long COVID, and has presented promising pre-clinical data at a symposium. Aethlon Medical Inc (NASDAQ:AEMD) benefits from a 43% cash tax rebate in Australia, which helps offset research costs and makes conducting trials there financially advantageous. Negative Points The decision to not proceed with the Indian trial may delay potential strategic partnerships or regulatory approvals, as the company focuses solely on the Australian trial. Despite cost reductions, Aethlon Medical Inc (NASDAQ:AEMD) will still need to raise additional funds to continue its clinical research, as it does not yet have approved products for sale. The company faces challenges in accelerating patient enrollment in its Australian trial, although efforts are being made to address this through additional sites and recruitment strategies. The efficacy of the hemo purifier in actual clinical settings remains to be proven, as pre-clinical results may not directly translate to patient outcomes. Aethlon Medical Inc (NASDAQ:AEMD) is still in the early stages of its clinical trials, and it may take time to gather sufficient data to inform dosing and treatment effects. Q & A Highlights Warning! GuruFocus has detected 2 Warning Sign with AEMD. Q: Can you confirm if the primary endpoint of the Australian study is safety, and if the first cohort has shown no adverse events related to the hemo purifier treatment? A: Yes, the primary endpoint is safety. We have successfully passed the first cohort with no adverse events, and an independent data safety monitoring board has recommended moving forward to the second cohort. (Dr. Steven La Rosa, Chief Medical Officer) Q: The pre-clinical data showed a 98.5% removal of extracellular vesicles in a simulated treatment. Should we expect similar results in the clinical study with actual patients? A: Laboratory results often differ from clinical outcomes. The true test will be the reduction observed in actual patients, and we hope to have data from the first cohort soon. (Dr. Steven La Rosa, Chief Medical Officer) Q: With the decision not to proceed with the Indian trial, what does this mean for your cash needs and strategic focus? A: We will need to continue raising funds, ideally with strategic partners. The decision to halt the Indian trial was more about avoiding delays in approval processes rather than cost savings. (Jim Frakes, CEO and CFO) Q: Are there any advantages to conducting clinical research in Australia compared to India, especially regarding costs and incentives? A: Australia offers a significant tax rebate of about 43%, which is not available in India. This rebate can make conducting research in Australia more cost-effective despite lower hospital costs in India. (Jim Frakes, CEO and CFO) Q: What efforts are being made to accelerate patient enrollment in the Australian trial? A: We are actively working on several initiatives, including pre-screening logs, recruiting additional sites, and using clinical trial liaisons and social media campaigns to speed up enrollment. (Dr. Steven La Rosa, Chief Medical Officer) For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
24 minutes ago
- Yahoo
Researchers put 3D-printed house to test on 50-ton shaking machine: 'These findings will be essential'
Researchers put 3D-printed house to test on 50-ton shaking machine: 'These findings will be essential' New sustainably constructed houses are being put to the test to see if they can withstand real-world weather conditions. A team of researchers from the University of Bristol has successfully mimicked the effects of an earthquake by placing 3D-printed concrete homes on a 50-ton shaking machine. They were testing their long-term durability, according to a press release, and monitoring any cracking, displacement, and potential failure points. 3D-printing commercial and residential structures has become "a rapidly emerging technology in the construction industry due to its potential to support rapid, resilient, affordable, and sustainable buildings," the press release said. And even though concrete is one of the most durable building materials, the new homes still need to undergo stress testing because they have unique properties and nontraditional geometries due to the 3D-printing process. "Insights from this study will help identify design parameters that optimise seismic performance, such as layer bonding strategies and reinforcement integration," said Dr. Raffaele De Risi, a lead researcher on the project, per the press release. "These findings will be essential for engineers, architects, and policymakers exploring the future of earthquake-resistant constructions." We are just beginning to see the future of construction with 3D printing, as the technology is likely to only improve and gain popularity. There's a need for quick and affordable housing all over the world, and automation like this makes it possible. People are already living in 3D-printed homes, choosing them because they're more cost-effective and eco-friendly than traditional builds and produce less waste. Some styles can even be built in just 24 hours. This efficiency means that they could be a solution for quickly generating housing in the aftermath of natural disasters, as well as emergency shelters and other needed infrastructure. "By testing the seismic resilience of 3D-printed concrete for the first time, we're not just exploring the future of construction — we're helping shape a safer, smarter, and more adaptive built environment," Dr. De Risi said. Would you trust a 3D-printed home in a natural disaster? Yes Depends on the disaster As much as traditional homes Nope Click your choice to see results and speak your mind. Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the the daily Crossword
Yahoo
24 minutes ago
- Yahoo
Jetstar passenger's warning after 'confusing' Bali flight ordeal: 'Don't wait'
A Jetstar passenger has hit out at the budget airline after an apparent airline tactic of overbooking flights left her potentially facing a long wait for another plane. Young Aussie Sky Kennedy told Yahoo News she was getting ready to fly home after a two-week solo adventure around Bali when, at the check-in desk, she was told she may be refused boarding because she hadn't pre-booked a seat. "When I got to the desk, the lady mentioned that the plane was full and because I hadn't selected a seat, that I didn't actually have one secured on that flight," Sky recalled for Yahoo News. Sky said she was "confused" because she'd booked the flight months ago. "She explained that even though I bought the ticket, because I hadn't selected a seat, it wasn't guaranteed," she said. Seat selection on Jetstar flights – do you have to buy a seat? Basic seat selection on Jetstar flights costs around $8, while seats closer to the front and on exit rows can go for up to $32. For Sky, she usually doesn't select a seat because she's "happy to sit anywhere". "If I had known that choosing a seat meant my booking wasn't secured, I would have, of course, selected one," she said. "But when you book online, it doesn't say that and even gives you the option to skip seat selection. If it's essential to secure your ticket, in my opinion, it should be included in the price or mentioned at the time of booking." Yahoo contacted Jetstar to find out if what Sky was told in Bali is airline policy. Jetstar advised that customers aren't required to pre-purchase seats to guarantee travel. If a flight is overbooked, Jetstar can choose passengers to change to another flight. It will provide affected passengers with compensation, reimbursement and assistance to secure another flight, the airline's policy says. Sky said once on board, the people next to her said they had booked the seat for their friend who was suddenly hospitalised with Covid. 😱 Jetstar passenger's incredible spot from window of Bali flight ✈️ Calls for Jetstar to change policy to resolve 'ridiculous' problem 🧳 Jetstar carry-on policy questioned after 'ridiculous' passenger request Sky, who shared her story online, said she learned that airlines are known to overbook flights, expecting that some passengers won't show up. On its website, Jetstar says flights may be overbooked "on rare occasions". Following her experience, Sky has warned Aussies to leave nothing to chance and simply pay the $8 fee. "Pay the extra however much it is for your seat and check in as soon as you can, don't wait until you get to the airport," she warned. Yahoo understands that Jetstar has apologised to Sky for the distress the incident caused her. On occasion, passengers aren't able to be accommodated due to a change in aircraft, weight restrictions, or, in rare circumstances, when a flight is overbooked. Do you have a story tip? Email: newsroomau@ You can also follow us on Facebook, Instagram, TikTok, Twitter and YouTube.
